Understanding and Applying Useful Instruments to Evaluate Bipolar Spectrum Disorder

This chapter emphasizes the importance of early detection and accurate assessment of bipolar spectrum disorders, which often go underdiagnosed, particularly bipolar II and subthreshold conditions. Early identification can reduce the substantial personal and societal burdens of bipolar disorder, including high suicide and unemployment rates. Various clinical tools help increase diagnostic accuracy and monitor symptom severity, though their effectiveness varies by context and subtype. Young Mania Rating Scale (YMRS) evaluates acute manic symptoms through 11 clinician-rated items, offering reliable severity measurement but limited applicability during depressive or mixed states. Bipolar Depression Rating Scale (BDRS) was created to capture the unique features of bipolar depression, including atypical and mixed symptoms often missed by standard depression scales. Mood Disorder Questionnaire (MDQ) is a widely used self-report screening tool with good sensitivity and specificity in clinical samples but lower sensitivity for bipolar II and in general populations. Modifications have been proposed to improve sensitivity. Hypomania Checklist-32 (HCL-32) and its revised version (HCL-32-R2) are self-report tools with higher sensitivity than MDQ, useful for detecting subtle hypomanic symptoms though less specific. Hypomanic Personality Scale (HPS) measures hypomanic traits in non-clinical populations, supporting research on vulnerability and personality correlates of bipolarity. Bipolar Spectrum Diagnostic Scale (BSDS) targets milder bipolar presentations and shows strong sensitivity and specificity. Screening tools are more effective in clinical than general populations due to higher disorder prevalence, making positive predictive value stronger in clinical contexts.